Fitbit launches platform aimed at health providers, expands with Humana

Digital wearables brand Fitbit has launched a new platform to connect healthcare providers with wearers, with healthcare services company Humana leading the charge.

The new offering, Fitbit Care, connects health plans, employers and health systems to health coaching and virtual care that can help improve wellness, disease management and prevention. Humana selected Fitbit Care as its preferred coaching solution for its employer group segment, potentially reaching five million members.

The partnership underscores the growing interest providers have in healthcare data of their enrollees.

“With the introduction of Fitbit Care, we continue to expand our healthcare offerings with a new, bundled subscription offering that can help improve outcomes for some of the most common and costly conditions in healthcare, such as diabetes and hypertension,” Adam Pellegrini, general manager of Fitbit Health Solutions, said in a statement.

The platform has several capabilities, including self-tracking for sleep, activity, heart rate and other metrics such as female health. This health data can support health goals, including personalized digital interventions. Enrollees in the health coaching component of the platform through their employer, health plan or health system have access to the app, Fitbit Plus, which allows individuals to communicate directly with their care team and health coach.

The app also integrates other health metrics including blood glucose, blood pressure and medication adherence. Fitbit acquired Twine Health, a coaching platform, in early 2018.

Humana and Fitbit have been partners since 2013 and the expansion of the partnership will continue to support healthy behaviors to reduce preventable chronic disease including diabetes and heart disease. Humana’s wellness programs and capabilities, such as Go365 and Humana Employee Assistance Program, aim to help employers control healthcare costs of their workers.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.